|
Prevalence and concentrations of serum T3, T4, TSH, IL-6 and IL-10 in the evaluated non-thyroidal illness subgroups of patients. |
|||
| VARIABLES |
MI (n = 20) |
CHF (n = 20) |
CRI (n = 20) |
|
|
|||
| T3 (n mol/L) |
0.63 ± 0.13 (70%) |
1.07 ± 0.47 (35%) |
1.14 ± 0.57 (40%) |
| T4 (n mol/L) |
75.65 ± 37.57 (70%) |
70.85 ± 22.68 (25%) |
78.2 ± 23.47 (45%) |
| TSH (μIU/L) |
1.23 ± 0.63 (72%) |
0.96 ± 0.32 (18%) |
1.04 ± 0.54 (26%) |
| IL-6 (ng/L) |
192.55 ± 15.12 |
82.95 ± 18.90 |
40.50 ± 14.38 |
| IL-10 (ng/L) |
122.95 ± 46.06 |
69.05 ± 44.04 |
30.4 ± 10.57 |
|
Values in parentheses represent the percentages of patients with lower than normal concentrations of the corresponding parameter. MI = myocardial infarction, CHF=congestive heart failure and CRI =chronic renal insufficiency. | |||
Abo-Zenah et al. BMC Endocrine Disorders 2008 8:1 doi:10.1186/1472-6823-8-1 |
|||